{"id":"W4379645953","doi":"10.1200/jco.2023.41.17_suppl.lba500","title":"Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: Primary results from the phase III NATALEE trial.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Letrozole; Breast cancer; Clinical endpoint; Tolerability; Internal medicine; Anastrozole; Population; Oncology; Interim analysis; Goserelin; Cancer; Surgery; Gynecology; Randomized controlled trial; Tamoxifen; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001126023,0.0002321772,0.001593645,0.0001069639,0.00005825485,0.00001291635,0.0001775223,0.0001646253,0.00007170611],"category_scores_gemma":[0.0004131212,0.0001162903,0.0002123557,0.0002736806,0.0003360513,0.0001691755,0.00004757347,0.0006973994,0.000009418523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003838703,"about_ca_system_score_gemma":0.001370262,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001046716,"about_ca_topic_score_gemma":0.0002622869,"domain_scores_codex":[0.9965333,0.0004311677,0.001911818,0.0003247281,0.0004766503,0.0003223052],"domain_scores_gemma":[0.9946154,0.003075915,0.001441677,0.0003032858,0.0002831328,0.0002806364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.4239222,0.002224968,0.07380299,0.00000252065,0.0004818736,0.0004218074,0.0003928413,0.000006899409,0.00002571492,0.000002992803,0.0002054637,0.4985097],"study_design_scores_gemma":[0.3718432,0.02681236,0.5740592,0.0001145192,0.0001292832,0.00006158945,0.00009906081,0.000004558206,0.00001876098,0.0001142472,0.02666365,0.00007953325],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9796555,0.001346893,0.000003914434,0.01700131,0.0007082021,0.0008796942,0.0002164745,0.00002105465,0.0001669518],"genre_scores_gemma":[0.9886286,0.006737418,0.0002820543,0.002404349,0.001552628,0.00004322954,0.00004425314,0.00003613333,0.0002712983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5002562,"threshold_uncertainty_score":0.474218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07422391342854126,"score_gpt":0.4508825997255233,"score_spread":0.3766586862969821,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}